Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Other Accumulated Expenses (2016 - 2026)

Orthofix Medical has reported Other Accumulated Expenses over the past 17 years, most recently at $106.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses rose 8.21% year-over-year to $106.2 million, compared with a TTM value of $106.2 million through Mar 2026, up 8.21%, and an annual FY2025 reading of $111.3 million, down 6.57% over the prior year.
  • Other Accumulated Expenses came in at $106.2 million for Q1 2026, down from $111.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $119.1 million in Q4 2024 to a low of $48.2 million in Q2 2022.
  • Median Other Accumulated Expenses over the past 5 years was $98.6 million (2023), compared with a mean of $90.6 million.
  • The sharpest move saw Other Accumulated Expenses decreased 27.88% in 2022, then soared 101.15% in 2023.
  • Over 5 years, Other Accumulated Expenses stood at $55.4 million in 2022, then surged by 89.45% to $104.9 million in 2023, then rose by 13.5% to $119.1 million in 2024, then fell by 6.57% to $111.3 million in 2025, then decreased by 4.51% to $106.2 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Other Accumulated Expenses are $106.2 million (Q1 2026), $111.3 million (Q4 2025), and $108.6 million (Q3 2025).